S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q1 2025

Baker Bros Advisors

Periodo: Q1 2025 · Depositato: 2025-05-15
Vedi su SEC EDGAR
AUM
$9.04B
Valore totale del portafoglio
Posizioni
89
Titoli dichiarati
Prima Posizione
ONC
26.5% $2.39B
Var. Trimestrali
+4 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-05-15) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ONCBeiGene, Ltd.$2.39B26.50%$272.17$297.65+9.4%
26.5%
INCYIncyte Corporation$1.86B20.60%$60.55$116.86+93.0%
20.6%
ACADACADIA Pharmaceuticals Inc.$712.2M7.88%$16.61$25.97+56.4%
7.9%
MDGLMadrigal Pharmaceuticals, Inc.$654.0M7.24%$331.23$528.10+59.4%
7.2%
SMMTSummit Therapeutics Inc.$471.2M5.21%$19.29$15.42-20.1%
5.2%
INSMInsmed Incorporated$410.5M4.54%$76.29$111.60+46.3%
4.5%
RYTMRhythm Pharmaceuticals, Inc.$296.9M3.29%$52.97$114.17+115.5%
3.3%
RVMDRevolution Medicines, Inc.$280.6M3.11%$35.36$189.24+435.2%
3.1%
KYMRKymera Therapeutics, Inc.$164.1M1.82%$27.37$113.51+314.7%
1.8%
ALKSAlkermes plc$148.0M1.64%$33.02$54.58+65.3%
1.6%
EWTXEdgewise Therapeutics, Inc.$135.4M1.50%$22.00$39.56+79.8%
1.5%
REPLReplimune Group, Inc.$107.7M1.19%$9.75$11.58+18.8%
1.2%
Insmed Incorporated$101.6M1.12%
1.1%
IMVTImmunovant, Inc.$93.3M1.03%$17.09$38.79+127.0%
1.0%
BCYCBicycle Therapeutics plc$92.4M1.02%$8.49$4.35-48.8%
1.0%
IMCRImmunocore Holdings plc$68.9M0.76%$29.67$32.50+9.5%
0.8%
KNSAKiniksa Pharmaceuticals International, plc$62.6M0.69%$22.21$64.53+190.5%
0.7%
ABCLAbCellera Biologics Inc.$61.4M0.68%$2.23$8.11+263.7%
0.7%
RAREUltragenyx Pharmaceutical Inc.$57.1M0.63%$36.21$33.47-7.6%
0.6%
DNLIDenali Therapeutics Inc.$50.7M0.56%$13.60$25.83+89.9%
0.6%
KODKodiak Sciences Inc.$48.6M0.54%$2.81$38.54+1271.5%
0.5%
NRIXNurix Therapeutics, Inc.$46.1M0.51%$11.88$23.97+101.8%
0.5%
ARGXargenx SE$46.0M0.51%$591.86$939.68+58.8%
0.5%
TRDAEntrada Therapeutics, Inc.$44.0M0.49%$9.04$7.72-14.6%
0.5%
CELCCelcuity Inc.$43.0M0.48%$10.11$107.95+967.8%
0.5%
GRALGRAIL, Inc.$41.6M0.46%$25.54$69.11+170.6%
0.5%
ROIVRoivant Sciences Ltd.$38.0M0.42%$10.09$35.13+248.2%
0.4%
IMTXImmatics N.V.$32.8M0.36%$4.51$9.95+120.6%
0.4%
STOKStoke Therapeutics, Inc.$30.8M0.34%$6.65$32.70+391.7%
0.3%
CERSCerus Corporation$26.9M0.30%$1.39$3.16+127.3%
0.3%

Attività Trimestre su Trimestre

Q1 2025 vs. Q4 2024

Nuove Posizioni (4)

TickerEmittenteNozionale
VRNAVerona Pharma plc$14.2M
RGLSRegulus Therapeutics Inc.$4.7M
SIONSionna Therapeutics, Inc.$4.2M
TECXTectonic Therapeutic, Inc.$1.8M

Posizioni Chiuse (8)

TickerEmittenteNozionale
Ionis Pharmaceuticals, Inc.$29.5M
KRYSKrystal Biotech, Inc.$26.6M
MIRMMirum Pharmaceuticals, Inc.$7.9M
ARVNArvinas, Inc.$7.8M
BMEABiomea Fusion, Inc.$5.6M
ARCTArcturus Therapeutics Holdings Inc.$2.6M
MRSNMersana Therapeutics, Inc.$1.6M
PTCTPTC Therapeutics, Inc.$0.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
PCVXVaxcyte, Inc.$20.2M+1211.0%
RCKTRocket Pharmaceuticals, Inc.$6.1M+1030.1%
IMVTImmunovant, Inc.$51.0M+219.6%+127.0%
NGNENeurogene Inc.$2.0M+120.4%
CELCCelcuity Inc.$8.0M+59.0%+967.8%
IMCRImmunocore Holdings plc$24.2M+53.3%+9.5%
INSMInsmed Incorporated$64.8M+7.5%+46.3%
ALKSAlkermes plc$27.8M+7.2%+65.3%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
IPSCCentury Therapeutics, Inc.$-0.7M-69.7%
CYPHLeap Therapeutics, Inc.$-3.3M-65.5%
XENEXenon Pharmaceuticals Inc.$-27.3M-65.0%
CMPXCompass Therapeutics, Inc.$-1.2M-64.9%
ACRVAcrivon Therapeutics, Inc.$-0.3M-56.9%
MRUSMerus N.V.$-9.5M-50.3%
CRSPCRISPR Therapeutics AG$-29.2M-50.0%
AKROAkero Therapeutics, Inc.$-8.3M-50.0%
Torna agli Hedge Fund